RYAN DENSON

H.R. 33/S. 199, United States-Taiwan Expedited Double-Tax Relief Act H.R. 2213/S. 998, Medical Supply Chain Resiliency Act H.R. 2548/S. 1241, Sanctioning Russia Act of 2025 H.R. 2665/S. 1272, Trade Review Act of 2025 H.R. 3193, United States-Republic of Korea Digital Trade Enforcement Act H.R. 5197/S. 3103, A bill to authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries H.R. 5926, Mexican Energy Trade Enforcement Act H.R. 6194/S. 2934, Protecting Americans from Russian Litigation Act of 2025 H.R. 6500, AGOA Extension Act H.R. 6504, Haiti Economic Lift Program Extension Act S. 3399, Digital Trade Promotion Act S. 3841, Last Sale Valuation Act of 2026 H.J. Res. 72, Relating to the National Emergency by the President on February 1, 2025 S.J. Res. 77, A joint resolution terminating the national emergency declared to impose duties on articles imported from Canada S.J. Res. 88, A joint resolution terminating the national emergency declared to impose global tariffs Various issues relating to U.S.-Korea digital trade and services; Congressional tariff authority; Adoption and Procedures of the Section 232 Steel and Aluminum Tariff Inclusions Process; reform of the World Trade Organization (WTO); implementation of the One Big Beautiful Bill Act, (P.L. 119-21); implementation of the Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); implementation of the Inflation Reduction Act, (P.L. 117-169); pharmaceutical price controls; patent-related issues, including patent linkage, patent term restoration, patent examination practices, and patent quality measures; regulatory data protection; efforts related to the U.S. International Development Finance Corporation (DFC); efforts related to ensuring a streamlined tariff refund process; efforts related to the advancement of tax treaties with Poland and Croatia; efforts related to identifying unfair foreign trade practices; efforts related to the extension of the African Growth and Opportunity Act (AGOA) (P.L. 106-200); efforts related to regulations issued by the Bank of Central African States (BEAC); efforts to preserve investment protections such as investor-state dispute settlement; efforts related to outlining critical mineral opportunities with key allies; efforts related to opposing international imposition of digital services taxes; efforts related to supporting strong digital trade rules; efforts to modify permanent normal trade relations treatment with China; U.S. economic and commercial relations with key trading partners across the globe; efforts to implement an outbound investment screening mechanism; efforts related to modernizing customs processes and updating tariff application procedures, including revisions to the de minimis statute; efforts related to the development of trade relations in the Indo-Pacific; efforts related to the development of trade relations in the Americas region; efforts related to the joint review of the U.S.-Mexico-Canada Agreement (USMCA); implementation and enforcement of U.S. free-trade agreements in force with 20 countries; implementation and enforcement of the agreements and ongoing negotiations of the WTO; trade policy concerns regarding customs duties on electronic transmissions; implementation of U.S. sanctions on Russia, including those related to Russias invasion of Ukraine; efforts related to sustaining momentum on providing aid to Ukraine; efforts related to reauthorization of the Export-Import Bank (Ex-Im Bank); reforms or changes to export controls; EU Digital Markets Act; EU Digital Services Act; EU Data Act; EU AI Act; IP issues relating to internet counterfeiting and digital piracy; IP issues relating to artificial intelligence; Global Internet Governance; policies and regulations restricting outbound data flows and data transfers; digital-related policies in the G20, G7, OECD, WTO, United Nations, and other international fora; digital trade policy considerations including cross-border data flows, digital service taxes, and issues of forced data localization, and forced disclosure of source code; international trade and regulatory practices impacting digital goods and services; international competition policy and related regulations; international artificial intelligence policy; international 5G policy and telecommunications infrastructure; international cybersecurity policy; international policies on standards development; international policies on data privacy; international digital health policies; international policies related to content moderation and intermediary liability; advancing international regulatory cooperation; consumer protection policy and related regulations; steel and aluminum tariffs; digital and tech sovereignty and sovereign cloud; IP issues at the WTO and the World Intellectual Property Organization; the EUs General Pharmaceutical Legislation; IP issues in Latin America, including enforcement of trade agreements and compulsory licenses and general IP standards and practices in Argentina, Mexico, Brazil, Colombia, and Chile; IP issues in India; USTRs Special 301 report and Review of Notorious Markets for Counterfeiting and Piracy; intersection of tariff-related policy and IP implications; U.S. Patent and Trademark Office IP Attache program; imposition of potential patent valuation fees; foreign pricing of pharmaceutical products; Most Favored Nation (MFN) reference pricing; ongoing practice of discretionary denials at the Patent Trial and Appeal Board; international competition policy, specifically FTC and DOJ involvement in the European Unions implementation of the EU Digital Markets Act; International Emergency Economic Powers Act (50 U.S.C. 1701(a)(b)) (IEEPA); IEEPA tariff refund implementation following the Supreme Courts decision in Learning Resources v. Trump; Directive (EU) 2024/2853 of the European Parliament and of the Council of 23 October 2024 on liability for defective products and repealing Council Directive 85/374/EEC; Mexicos Tax Administration Service (SAT); recommended changes to the EUs Corporate Sustainability Due Diligence Directive (CS3D); supply chain and defense industrial base issues; development of the National Defense Authorization Act for Fiscal Year 2027

H.R. 4016, Department of Defense Appropriations Act, 2026 H.R. 4121, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 4213, Department of Homeland Security Appropriations Act, 2026 H.R. 4553, Energy and Water Development and Related Agencies Appropriations Act, 2026 H.R. 5166, Financial Services and General Government Appropriations Act, 2026 Various issues relating to debt ceiling/limit, budget caps, budget sequestration, and budget reconciliation; budget reconciliation legislation and related spending levels; request for IRIS reform in FY26 Appropriations Legislation; H-2B Cap Relief Language in FY25 Homeland Security Appropriations Legislation; funding for Air Traffic Control System (FAA); implementation of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (P.L. 118-159); implementation of the Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); implementation of the Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); implementation of the One Big Beautiful Bill Act, (P.L. 119-21); Fiscal Year 2026 National Defense Authorization Act related to perfluoroalkyls and polyfluoroalkyl chemicals (PFAS); Border Water Infrastructure Program; funding for the National Endowment for Democracy and Center for International Private Enterprise; funding issues related to the Department of Homeland Security; funding issues related to the Department of Health and Human Services implementation of the IRAs Medicare drug pricing negotiation provisions; funding issues related to the U.S. Patent and Trademark Office (USPTO), including the potential imposition of patent valuation fees; IP-related concerns with right to repair issues in the National Defense Authorization Act (NDAA)

Potential legislation amending the Inflation Reduction Act (P.L. 117-169) Potential legislation seeking to impose pharmaceutical price controls to private sector payers Potential legislation related to artificial intelligence and intellectual property rights Potential legislation related to digital piracy Potential legislation related to changes in Patent Trial and Appeal Board Proceedings Potential legislation related to implementing most favored nation style reference pricing Potential legislation related to detection of counterfeit imports Potential legislation addressing the appointment of the Register of Copyrights Potential legislation related to protecting consumers from counterfeit goods online Various issues relating to implementation of Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); patent examination practices and patent quality; patent filing fees and potential patent valuation fees; IP issues related to counterfeiting; pharmaceutical price controls; IP issues related to prescription drug pricing and labeling; implementation of the Inflation Reduction Act of 2022, Drug Price Negotiation Program (P.L. 117-169, subtitle B)